$143.7 Million
Solid Biosciences Inc.
Follow-On Offering
Active Bookrunner
$149.9 Million
ESSA Pharma Inc.
Follow-On Offering
Active Bookrunner
$160.4 Million
Nurix Inc.
Follow-On Offering
Active Bookrunner
$140.0 Million
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
$114.9 Million
CytomX Therapeutics Inc.
Follow-On Offering
Active Bookrunner
$57.0 Million
Oncorus, Inc.
Follow-On Offering
Active Bookrunner
$168.0 Million
Dyne Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$356.7 Million
American Well Corporation
Follow-On Offering
Active Bookrunner
$459.9 Million
Arvinas
Follow-On Offering
Active Bookrunner
$92.1 Million
Ocular Therapeutix, Inc.
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.